Pharmaceuticals
Pfizer Company Briefing
This is a company juggling a massive patent cliff with a ten billion dollar bet on obesity.
2026-09-13 · 13:55
Podcast show
Listen to Pharmaceuticals briefings, then search any related company or industry for a report and analyst debate podcast in minutes.
Pharmaceuticals
This is a company juggling a massive patent cliff with a ten billion dollar bet on obesity.
2026-09-13 · 13:55
Pharmaceuticals
A $68 billion market navigating a critical structural inflection.
2026-08-04 · 19:16
Pharmaceuticals
A $62 billion industry undergoing fundamental restructuring.
2026-08-04 · 19:11
Pharmaceuticals
A $178 billion market facing a fundamental question about its economic foundation.
2026-08-04 · 22:36
Pharmaceuticals
A $500 billion global market standing at a critical structural juncture.
2026-08-04 · 16:34
Pharmaceuticals
A $278 billion market where everything hinges on one structural tension.
2026-08-04 · 13:04
Pharmaceuticals
A $52 billion industry — before we get to any conclusions.
2026-08-04 · 14:28
Pharmaceuticals
A $180 billion market facing a fundamental structural question about how it sustains itself.
2026-08-04 · 20:04
Pharmaceuticals
Immunology Drugs briefing from AskCyborg — featured in Pharmaceuticals.
2026-08-04 · 15:12
Pharmaceuticals
GLP-1 receptor agonist drugs for obesity and weight management, including semaglutide and tirzepatide; the pharmaceutical weight-loss market.
2026-08-04 · 14:23
Pharmaceuticals
Generic Drugs briefing from AskCyborg — featured in Pharmaceuticals.
2026-08-04 · 15:10
Pharmaceuticals
A $65 billion sector facing a critical structural inflection point.
2026-08-04 · 15:10
Pharmaceuticals
A $68 billion market in structural flux.
2026-08-04 · 18:12
Pharmaceuticals
A $180 billion industry at a critical inflection point.
2026-08-04 · 17:57